191 related articles for article (PubMed ID: 18252943)
21. Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction.
Lebrun JJ; Ali S; Ullrich A; Kelly PA
J Biol Chem; 1995 May; 270(18):10664-70. PubMed ID: 7537736
[TBL] [Abstract][Full Text] [Related]
22. Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.
Pedraz-Cuesta E; Fredsted J; Jensen HH; Bornebusch A; Nejsum LN; Kragelund BB; Pedersen SF
Mol Endocrinol; 2016 Jul; 30(7):693-708. PubMed ID: 27176613
[TBL] [Abstract][Full Text] [Related]
23. Prolactin activates tyrosyl phosphorylation of insulin receptor substrate 1 and phosphatidylinositol-3-OH kinase.
Berlanga JJ; Gualillo O; Buteau H; Applanat M; Kelly PA; Edery M
J Biol Chem; 1997 Jan; 272(4):2050-2. PubMed ID: 8999900
[TBL] [Abstract][Full Text] [Related]
24. Different intracellular signalling pathways triggered by an anti-prolactin receptor (PRLR) antibody: Implication for a signal-specific PRLR agonist.
Kan QE; Su Y; Yang H; Man H
Int J Biol Macromol; 2016 Jan; 82():892-7. PubMed ID: 26526176
[TBL] [Abstract][Full Text] [Related]
25. A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription.
Lebrun JJ; Ali S; Goffin V; Ullrich A; Kelly PA
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):4031-5. PubMed ID: 7537382
[TBL] [Abstract][Full Text] [Related]
26. The Janus kinase 2 is required for expression and nuclear accumulation of cyclin D1 in proliferating mammary epithelial cells.
Sakamoto K; Creamer BA; Triplett AA; Wagner KU
Mol Endocrinol; 2007 Aug; 21(8):1877-92. PubMed ID: 17519353
[TBL] [Abstract][Full Text] [Related]
27. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.
Sakamoto K; Triplett AA; Schuler LA; Wagner KU
Oncogene; 2010 Sep; 29(39):5359-69. PubMed ID: 20639901
[TBL] [Abstract][Full Text] [Related]
28. SHP-2 regulates SOCS-1-mediated Janus kinase-2 ubiquitination/degradation downstream of the prolactin receptor.
Ali S; Nouhi Z; Chughtai N; Ali S
J Biol Chem; 2003 Dec; 278(52):52021-31. PubMed ID: 14522994
[TBL] [Abstract][Full Text] [Related]
29. GHR/PRLR Heteromultimer Is Composed of GHR Homodimers and PRLR Homodimers.
Liu Y; Zhang Y; Jiang J; Lobie PE; Paulmurugan R; Langenheim JF; Chen WY; Zinn KR; Frank SJ
Mol Endocrinol; 2016 May; 30(5):504-17. PubMed ID: 27003442
[TBL] [Abstract][Full Text] [Related]
30. Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors.
DaSilva L; Howard OM; Rui H; Kirken RA; Farrar WL
J Biol Chem; 1994 Jul; 269(28):18267-70. PubMed ID: 8034567
[TBL] [Abstract][Full Text] [Related]
31. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
Tomic S; Chughtai N; Ali S
Mol Cell Endocrinol; 1999 Dec; 158(1-2):45-54. PubMed ID: 10630404
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate-1, -2, and -3, their association with p85 phosphatidylinositol 3-kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase.
Yamauchi T; Kaburagi Y; Ueki K; Tsuji Y; Stark GR; Kerr IM; Tsushima T; Akanuma Y; Komuro I; Tobe K; Yazaki Y; Kadowaki T
J Biol Chem; 1998 Jun; 273(25):15719-26. PubMed ID: 9624169
[TBL] [Abstract][Full Text] [Related]
33. Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner.
Neradugomma NK; Subramaniam D; Tawfik OW; Goffin V; Kumar TR; Jensen RA; Anant S
Carcinogenesis; 2014 Apr; 35(4):795-806. PubMed ID: 24265293
[TBL] [Abstract][Full Text] [Related]
34. Prolactin promotes hepatocellular carcinoma through Janus kinase 2.
Yeh YT; Lee KT; Tsai CJ; Chen YJ; Wang SN
World J Surg; 2012 May; 36(5):1128-1135. PubMed ID: 22392353
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain.
Kline JB; Rycyzyn MA; Clevenger CV
Mol Endocrinol; 2002 Oct; 16(10):2310-22. PubMed ID: 12351696
[TBL] [Abstract][Full Text] [Related]
36. New mechanisms for PRLr action in breast cancer.
Clevenger CV; Gadd SL; Zheng J
Trends Endocrinol Metab; 2009 Jul; 20(5):223-9. PubMed ID: 19535262
[TBL] [Abstract][Full Text] [Related]
37. Role of tyrosine phosphorylation in potassium channel activation. Functional association with prolactin receptor and JAK2 tyrosine kinase.
Prevarskaya NB; Skryma RN; Vacher P; Daniel N; Djiane J; Dufy B
J Biol Chem; 1995 Oct; 270(41):24292-9. PubMed ID: 7592639
[TBL] [Abstract][Full Text] [Related]
38. Impaired turnover of prolactin receptor contributes to transformation of human breast cells.
Plotnikov A; Varghese B; Tran TH; Liu C; Rui H; Fuchs SY
Cancer Res; 2009 Apr; 69(7):3165-72. PubMed ID: 19276348
[TBL] [Abstract][Full Text] [Related]
39. JAK2 and STAT5, but not JAK1 and STAT1, are required for prolactin-induced beta-lactoglobulin transcription.
Han Y; Watling D; Rogers NC; Stark GR
Mol Endocrinol; 1997 Jul; 11(8):1180-8. PubMed ID: 9212064
[TBL] [Abstract][Full Text] [Related]
40. The last proline of Box 1 is essential for association with JAK2 and functional activation of the prolactin receptor.
Pezet A; Buteau H; Kelly PA; Edery M
Mol Cell Endocrinol; 1997 May; 129(2):199-208. PubMed ID: 9202403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
